Publication
Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial.
Journal Paper/Review - Oct 27, 2023
Urwyler Pascal, Leimbacher Marina, Charitos Panteleimon, Moser Stephan, Fehrman-Ekholm Ingela, Trendelenburg Marten, Thoma Reto, Sumer Johannes, Camacho-Ortiz Adrián, Bacci Marcelo R, Huber Lars Chistian, Stüssi-Helbling Melina, Albrich Werner, Sendi Parham, Osthoff Michael
Urwyler, Pascal
1
0
Leimbacher, Marina
Charitos, Panteleimon
1
0
Moser, Stephan
1
0
Fehrman-Ekholm, Ingela
1
0
Trendelenburg, Marten
6
0
Thoma, Reto
5
0
Sumer, Johannes
Division of Infectious Diseases, Infection Prevention and Travel Medicine · Dept. I
9
0
Camacho-Ortiz, Adrián
1
0
Bacci, Marcelo R
1
0
Huber, Lars Chistian
1
0
Stüssi-Helbling, Melina
1
0
Albrich, Werner
chief of serviceDivision of Infectious Diseases, Infection Prevention and Travel Medicine · Dept. I
107
12
Sendi, Parham
6
0
Osthoff, Michael
7
0